Article
EPLIN: a fundamental actin regulator in cancer metastasis?
9 Sept 2015
Abstract excerpt
Treatment of malignant disease is of paramount importance in modern medicine. In 2012, it was estimated that 162,000 people died from cancer in the UK which illustrates a fundamental problem. Traditional treatments for cancer have various drawbacks, and this creates a considerable need for specific, molecular targets to overcome cancer spread. Epithelial protein lost in neoplasm (EPLIN) is an actin-associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
